The FDA has approved Dupixent (dupilumab) for the treatment of children (aged 2 to 11 years) with chronic spontaneous urticaria (CSU).
MedPage Today on MSN
Dupilumab Improves Esophageal Distensibility in Eosinophilic Esophagitis
The monoclonal antibody countered some esophageal restructuring caused by inflammatory dri ...
You can inject Mounjaro subcutaneously (under the skin) at three sites: your abdomen, thigh, or upper arm. But be sure to change sites weekly and follow all instructions to inject Mounjaro correctly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results